Chemical metabolism of medicinal compounds from natural botanicals

Current Medicinal Chemistry

Volumn 19, Issue 11, 2012, Pages 1682-1705

  Lu, Q ^a   Jiang, J G ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Chemical metabolism; Drug metabolism; Natural products; Pharmacological activity; Traditional Chinese medicine (TCM)

Indexed keywords

ACONITINE; ALKALOID; ANISODAMINE; ANISODINE; BAICALEIN; BAICALIN; BERBERINE; BRUCINE; CLAUSENAMIDE; DRUG METABOLITE; ESTER; FLAVONOID; GINSENOSIDE; ISORHYNCHOPHYLLINE; LIGNAN; OXYMATRINE; PHENOL DERIVATIVE; PILOCARPINE; PLANT MEDICINAL PRODUCT; PUERARIN; QUINONE DERIVATIVE; SAPONIN; SCOPOLAMINE; SECURININE; STILBENE DERIVATIVE; STRYCHNINE; TERPENOID DERIVATIVE; TETRAMETHYLPYRAZINE; TRIGONELLINE; UNINDEXED DRUG;

ACONITE; ANALGESIC ACTIVITY; ANALYTIC METHOD; ANTIBIOSIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATROPA BELLADONNA; CHINESE MEDICINE; CLAUSENA; COPTIS CHINENSIS; CYPERACEAE; DIPTEROCARPACEAE; DRUG DETERMINATION; DRUG MECHANISM; DRUG METABOLISM; DRUG OVERDOSE; DRUG TRANSFORMATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGUSTICUM; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PILOCARPUS; SCUTELLARIA; SOPHORA FLAVESCENS; TANDEM MASS SPECTROMETRY; THIN LAYER CHROMATOGRAPHY; TRIGONELLA; ULCER; UNCARIA;

ANIMALS; BIOLOGICAL AGENTS; BIOTRANSFORMATION; DRUGS, CHINESE HERBAL; HUMANS;

EID: 84860519028     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712799945076     Document Type: Article

References (102)

1. Baillie, T. A. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. Chem. Res. Toxicol., 2008, 21, 129-137.
2. Naito, S.; Furuta, S.; Yoshida, T.; Kitada, M.; Fueki, O.; Unno, T.; Ohno, Y.; Onodera, H.; Kawamura, N.; Kurokawa, M.; Sagami, F.; Shinoda, K.; Nakazawa, T.; Yamazaki, T. Current opinion: safety evaluation of drug metabolites in development of pharmaceuticals. J. Toxicol. Sci., 2007, 32, 329-341.
3. Yokoi, T. Current topics in drug metabolism and drug toxicity. Drug Metab. Pharmacok., 2011, 26, 1-2.
4. Qu M. Metabolism of traditional Chinese medicines. Jiujiang Med. J., 2007, 22, 48-52.
5. Kang, M. J.; Song, W. H.; Shim, B. H.; Oh, S. Y.; Lee, H. Y.; Chung, E. Y.; Sohn, Y.; Lee, J. Pharmacologically active metabolites of currently marketed drugs: potential resources for new drug discovery and development. Yakugaku Zasshi, 2010, 130, 1325-1337.
6. Grynkiewicz, G.; Gadzikowska, M. Tropane alkaloids as medicinally useful natural products and their synthetic derivatives as new drugs. Pharmacol. Rep., 2008, 60, 439-463.
7. Sun, Y.; Zhang, H. G.; Shi, X. G.; Duan, M. Y.; Zhong, D. F. Study on metabolites of aconitine in rabbit urine. Acta Pharm. Sin., 2002, 37, 781-783.
8. Wang, Z. H.; Wen, J.; Chen, Y. H.; He, Y. Study on determination of metabolites of aconitine in rat urine by HPLC/MS. Chin. J. Forens. Ic. Med., 2006, 21, 88-90.
9. Zhao, Y. F.; Song, F. R.; Yue, H.; Guo, X. H.; Li, H. L.; Liu, Z. Q.; Liu, S. Y. Studies on the biotransformation of 16-O-demethyldeoxyaconitine of the metabolite of aconitine in human intestinal bacteria. Chinese J. Anal. Chem., 2007, 35, 1711-1715.
10. Zhao, Y. F.; Song, F. R.; Yue, H.; Guo, X. H.; Li, H. L.; Liu, Z. Q.; Liu, S. Y. Biotransformation of deoxyaconitine of metabolite of aconitine by human intestinal bacteria and electrospray ionization tandem mass spectrometry. Chem. J. Chinese U., 2007, 28, 2051-2055.
11. Qiu, F.; Zhu, Z. Y.; Piao, S. J.; Zhang, J. Y.; Yao, X. S. Study on urinary metabolites of orally administered berberine chloride in humans. Chin. Med. Res. & Clin., 2005, 3, 6-9.
12. Qiu, F.; Zhu, Z. Y.; Kang, N.; Piao, S. J.; Qin, G. Y.; Yao, X. S. Isolation and identification of urinary metabolites of berberine in rats and humans. Drug Metab. Dispos., 2008, 36, 2159-2165.
13. Liu, Y. T.; Hao, H. P.; Xie, H. G.; Lv, H.; Liu, C. X.; Wang, G. J. Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats. J. Pharm. Sci., 2009, 98, 4391-4401.
14. Li, Y.; Ren, G.; Wang, Y. X.; Kong, W. J.; Yang, P.; Wang, Y. M.; Li, Y. H.; Yi, H.; Li, Z. R.; Song, D. Q.; Jiang, J. D. Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes. J. Transl. Med., 2011, 9, 1-10.
15. Chen, Y.; Shen, S. L.; Chen, H. X.; Pan, J.; Han, F. M. HPLC-MSn analysis of trigonelline and its metabolites in rat urine. Acta Pharm. Sin., 2006, 41, 216-220.
16. Chen, H. X.; Chen, Y. Analysis of anisodamine and its metabolites in homogenized liver of rat by liquid chromatography-tandem mass spectrometry. J. Hubei Univ. (Nat. Sci.), 2006, 28, 296-298.
17. Chen, H. X.; Du, P.; Han, F. M.; Chen, Y. Detection of anisodamine and its metabolites in rat feces by tandem mass spectrometry. Acta Pharm. Sin., 2006, 41, 1166-1169.
18. Chen, Y.; Du, P.; Han, F. M.; Chen, H. X. Characterization of in vivo and in vitro metabolic pathway of anisodamine by liquid chromatography-tandem mass spectrometry. J. Liq. Chromatogr. R. T., 2007, 30, 1933-1949.
19. Chen, H. X.; Du, P.; Han, F. M.; Chen, Y. Study on the metabolism of scopolamine in rat intestinal flora. J. Hubei Univ. (Nat. Sci.), 2006, 28, 414-416.
20. Chen, H. X.; Du, P.; Han, F. M.; Chen, Y. Identification of scopolamine and its metabolites in rat plasma by liquid chromatography-tandem mass spectrometry. Chin. J. Anal. Chem., 2006, 34, 851-854.
21. Chen, H. X.; Du, P.; Han, F. M.; Chen, Y. Analysis of anisodine and its metabolites in homogenized liver of rat by liquid chromatography-tandem mass spectrometry. Chin. J. Anal. Chem., 2006, 34, 1729-1732.
22. Chen, H. X.; Chen, Y.; Zhang, H. S. Identification of anisodine and its metabolites in rat intestinal flora by liquid chromatography-tandem mass spectrometry. J. Anal. Sci., 2006, 22, 373-376.
23. Li, X. H.; Zhang, J. L.; Zhou, T. H. The metabolic transformation of (-) - securinine. Acta Pharm. Sin., 2002, 37, 288-293.
24. Wang, L.; Wang, Y. W.; Chen, G.; Yuan, H. M. Studies on metabolites of pilocarpine in human urine using high-performance liquid chromatography with tandem mass spectrometry. Chem. J. Chin. Univ., 2005, 26, 2230-2232.
25. Zhang, Z.; Qi, Y. Study on metabolites of pilocarpine in rat urine using highperformance liquid chromatography with tandem mass spectrometry. Med. World, 2006, 9, 53-54.
26. Yu, J. X.; Xie, X. L.; Wu, Q.; Huang, X. N.; Sun, A. S.; Shi, J. S. Mass spectroscopic identification and pharmacological effect of the metabolite of isorhynchophylline. Chin. Remedies & Clin., 2005, 5, 7-9.
27. Chen, Y.; Chen, H. X.; Du, P.; Han, F. M. HPLC-electrospray ionization ion trap tandem mass spectrometry analysis of oxymatrine and its metabolites in rat urine. Acta Pharm. Sin., 2005, 40, 740-745.
28. A, J. Y.; Wang, G. J.; Liu, X. Q.; Jiang, D. Y.; Liu, J. H. Study on the metabolites of guanfu base a hydrochloride in rat urine by high performance liquid chromatograph-mass spectrum. Acta Pharm. Sin., 2002, 37, 283-287.
29. Wang, P.; Jin, X.; Qi, M. L.; Fang, L. Liquid chromatography-mass spectrometry method for determination of tetramethylpyrazine and its metabolite in dog plasma. J. Chromatogr. B., 2004, 813, 263-268.
30. Tang, G. H.; Jiang, G. H.; Wang, S. Z.; Zheng, L. F. Studies on metabolic transformation of perlolyrine in rats. Acta Pharm. Sin., 2000, 35, 457-460.
31. Zhang, W. J.; Zhou, T. H.; Cui, Y. Y. The in vitro metabolism of hainanensine derivative HH07A by rat liver microsomes. Acta Pharm. Sin., 1997, 32, 116-120.
32. Zhang, W. J.; Zhou, T. H. Studies on urinary metabolites of HH07A, a derivative of hainanensine, in rats. Acta Pharm. Sin., 1998, 33, 212-216.
33. Yao, Q. Q.; Wang, Y.; Yang, S. M.; Wang, M. Z. LC-MS analysis of (+) and (-)-clausenamide and their metabolites in rat liver microsomes. Chin. J. Pharmaceut. Anal., 2000, 20, 3-7.
34. Yao, Q. Q.; Wang, Y.; Yang, S. M.; Wang, M. Z. Biotransformation of (+)-and (-)-clausenamide in rats. Acta Pharm. Sin., 2001, 36, 224-228.
35. Zhu, C. J.; Zhang, J. T. Identification of rat cytochrome P450 forms involved in the metabolism of clausenamide enantiomers. Chirality, 2003, 15, 448-455.
36. Zhu, C. J.; Zhang, J. T. Stereoselective pharmacokinetics of clausenamide enantiomers and their major metabolites after single intravenous and oral administration to rats. Chirality, 2003, 15, 668-673.
37. Guo, J. F.; Chen, X. Y.; Zhong, D. F. Identification of strychnine, brucine and their metabolites in body fluids by liquid chromatography- electrospray ion trap mass spectrometry. Chin. J. Pharmaceut. Anal., 2001, 21, 167-170.
38. Lotito, S. B.; Zhang, W. J.; Yang, C. S.; Crozier, A.; Frei, B. Metabolic conversion of dietary flavonoids alters their anti-inflammatory and antioxidant properties. Free Radical Bio. Med., 2011, 51, 454-463.
39. Terao, J. Dietary Flavonoids as Antioxidants. Food Factors Health Promotion, 2009, 61, 87-94.
40. Rice-Evans, C. Flavonoids and isoflavones (phytoestrogens): absorption, metabolism, and bioactivity. Free Radical Bio. Med., 2004, 36, 827-828.
41. Che, Q. M.; Huang, X. L.; Li, Y. M.; Zhang, K.; Akao, T.; Hattori, M. Studies on metabolites of baicalin in human urine. China J. Chin. Mater. Med., 2001, 26, 768-769.
42. Wang, Y. Studies on the metabolism of baicalin in rat and biological activities of the metabolites [Ph. D. thesis]. Shenyang City, China: Shenyang Pharmaceutical University, 2004.
43. Xing, J. Study on the absorption and metabolism of baicalin in animals [Ph. D. thesis]. Shenyang City, China: Shenyang Pharmaceutical University, 2005.
44. Feng, N. P.; Di, B.; Liu, W. Y. Comparison of the metabolism of baicalin in rats orally administered with Radix scutellariae extract and Shuang-Huang-Lian extract. Chem. Pharm. Bull., 2005, 53, 978-983.
45. Yang, C. M.; Hou, S. X.; Zhang, Z. R. Recent advances in metabolic chemistry of traditional Chinese drugs. Chin. Tradit. Herb. Drugs, 2000, 31, 641-644.
46. Cui, S. M.; Zhao, C. S.; Gao, K.; Mao, J. J.; He, Z. G. Determination of puerarin in rat liver microsomes by LC-MS and its pharmacokinetics. J. Shenyang Pharmaceut. Univ., 2007, 24, 32-36.
47. Wen, B. Y.; Li, H.; Wang, L.; Wang, S. C. Metabolic kinetic of puerarin in beagle liver microsomal by HPLC-ESI-MS. China J. Chin. Mater. Med., 2008, 33, 2834-2837.
48. Day, A. J.; Mellon, F.; Barron, D.; Sarrazin, G.; Morgan, M. R. A.; Williamson, G. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radical Res., 2001, 35, 941-952.
49. Chen, F.; Fu, N. G.; Ren, S. Z.; Wei, N.; Zhang, J. Q. Determination of quercetin metabolites in rat plasma by liquid chromatography-mass spectrometry. Chin. Pharm. J., 2008, 43, 225-227.
50. Liu, T. H.; Wang, Y.; Wang, B. X.; Wu, L. J. Studies on the metabolism of icariin by intestinal bacteria part I: the transformation of icariin by intestinal flora. Chin. Tradit. Herb. Drugs, 2000, 31, 834-837.
51. Xu, W.; Zhang, Y. P.; Zhang, W. D.; Zhang, X. M.; Shen, Z. Y. Metabolism of icariin and icariside II by rat intestinal bacteria in vitro. World Sci. Technol./Mod. Tradit. Chin. Med. Mater. Med., 2006, 8, 98-100.
52. Gradolatto, A.; Canivenc-Lavier, M. C.; Basly, J. P.; Siess, M. H.; Teyssier, C. Metabolism of apigenin by rat liver phase I and phase II enzymes and by isolated perfused rat liver. Drug Metab. Dispos., 2004, 32, 58-65.
53. Sun, G. L.; Qian, D. W.; Duan, J. A.; Li, X. M.; Wan, J. Y.; Guo, J. M. UPLCQ-TOF-MS analysis of naringin and naringenin and its metabolites in rat plasma after intragastrical administration of alcohol extract of exocarpium Citri grandis. China J. Chin. Mater. Med., 2010, 35, 1580-1585.
54. Kim, D. H.; Bae, E. A.; Han, M. J. Anti-helicobacter pylori activity of the metabolites of poncirin from Poncirus trifoliate by human intestinal bacteria. Biol. Pharm. Bull., 1999, 22, 422-424.
55. Paek, I. P.; Moon, Y.; Kim, J.; Ji, H. Y.; Kim, S. A.; Sohn, D. H.; Kim, J. B.; Lee, H. S. Pharmacokinetics of a ginseng saponin metabolite compound K in rats. Biopharm. Drug Dispos., 2006, 27, 39-45.
56. Sun, H. X.; Xie, Y.; Ye, Y. P. Advances in saponin-based adjuvants. Vaccine, 2009, 27, 1787-1796.
57. Zhang, Y. X.; Chen, X. Y.; Zhao, W. Q. Advances in studies on biotransformation of ginsenosides. J. Shenyang Pharmaceut. Univ., 2008, 25, 419-422.
58. Wang, Y.; Liu, T. H.; Wang, W.; Wang, B. X. Research on the transformation of ginsenoside Rg1 by intestinal flora. China J. Chin. Mater. Med., 2001, 26, 188-190.
59. Chen, X.; Zhou, Q. L.; Wang, B. X. The metabolism of ginsenoside Rb1 by intestinal bacteria. Acta Pharm. Sin., 1999, 34, 410-414.
60. Yang, L.; Xu, S. J.; Zeng, X.; Wu, Z. F.; Deng, Y. H.; Liu, Y. M.; Deng, S. G.; Ou, R. M. In vivo rat metabolism studies of ginsenoside-Rb1. Chem. J. Chin. Univ., 2006, 27, 1042-1044.
61. Yang, L.; Xu, S. J.; Zeng, X.; Liu, Y. M.; Deng, S. G.; Wu, Z. F.; Ou, R. M. Determination of ginsenoside Rd and its metabolites in rat urine by LC-MS. Acta Pharm. Sin., 2006, 41, 742-746.
62. Akao, T.; Hayashi, T.; Kobashi, K.; Kanaoka, M.; Kato, H.; Kobayashi, M.; Takeda, S.; Oyama, T. Intestinal bacterial hydrolysis indispensable to absorption of 18 beta-glycyrrhetic acid after oral administration of glycyrrhizin in rats. J. Pharm. Pharmacol., 1994, 46, 135-137.
63. Yan, M. Z. The metabolism of saikosaponin by human intestinal bacteria. Foreign Med. Sci., 2001, 23, 156-158.
64. Chen, J. Y.; Wu, L. J.; Teng, H. L.; Liu, K. Study on aescin metabolism in intestinal flora in vitro. Chin. Tradit. Herb. Drugs, 2003, 34, 970-973.
65. Ma, H. Y.; Zhou, Q. L.; Wang, B. X. Studies on the metabolism of DX by intestinal bacteria and the absorbed components in serum. China Pharm., 2002, 13, 204-205.
66. Shen, L.; Xu, D. S.; Feng, Y.; Lin, X.; Wu, X. R. Effect of intestinal bacteria on metabolism of ophiopognin saponin D' in rats. China J. Chin. Mater. Med., 2005, 30, 618-620.
67. Wang, J. H.; Li, X. Study on the metabolism of pseudo-ginsenoside F11 in rats. Acta Pharm. Sin., 2001, 36, 427-431.
68. Yang, X. F.; Song, C. Q. Studies on the metabolism of gentiopcroside by rat intestinal flora. China J. Chin. Mater. Med., 2000, 25, 673-676.
69. Song, C. Q.; Yang, X. F.; Hu, Z. B. The metabolism of gentiopicroside by human intestinal bacteria. Lishizhen Med. Mater. Med. Res., 2001, 12, 1-2.
70. Yang, X. W.; Zhang, J. Y.; Xu, W. Biotransformation of mogroside III by human intestinal bacteria. J. Peking Univ. (Health Sci.), 2007, 39, 657-662.
71. Zhang, D. M.; Miyase, T.; Noguchi, H.; Tanizawa, H.; Ma, W. Y.; Chen, D. Y. Identification of metabolites of reinioside C, a triterpene saponin from the roots of Polygala fallax Hemsl. Chem. J. Chin. Univ., 2002, 23, 63-67.
72. Gershenzon, J.; Dudareva, N. The function of terpene natural products in the natural world. Nat. Chem. Biol., 2007, 3, 408-414.
73. He, X. J.; Li, J. K.; Gao, H.; Qiu, F.; Hu, K.; Cui, X. M.; Yao, X. S. Four new andrographolide metabolites in rats. Tetrahedron, 2003, 59, 6603-6607.
74. He, X. J.; Li, J. K.; Gao, H.; Qiu, F.; Cu, X. M.; Yao, X. S. Six new andrographolide metabolites in rats. Chem. Pharm. Bull., 2003, 51, 586-589.
75. Cui, L.; Qiu, F.; Wang, N. L.; Yao, X. S. Four new andrographolide metabolites in human urine. Chem. Pharm. Bull., 2004, 52, 772-775.
76. Cui, L.; Qiu, F.; Yao, X. S. Isolation and identification of seven glucuronide conjugates of andrographolide in human urine. Drug Metab. Dispos., 2005, 33, 555-562.
77. Cui, L.; Qiu, F.; Wang, N. L.; Yao, X. S. A new glucuronidated metabolite of andrographolide in human. Chin. Chem. Lett., 2005, 16, 369-371.
78. Cui, L.; Chan, W.; Qiu, F.; Cai, Z. W.; Yao, X. S. Identification of four urea adducts of andrographolide in humans. Drug Metab. Lett., 2008, 2, 261-268.
79. Li, Z.; Wang, K.; Chen, Y. R.; Wu, X. Y.; Su, C. Y. Studies on metabolite of â-elemene in rat bile. Acta Pharm. Sin., 2000, 35, 829-831.
80. Bardelmeijer, H. A.; Oomen, I. A. M.; Hillebrand, M. J. X.; Beijnen, J. H.; Schellens, J. H. M.; van Tellingen, O. Metabolism of paclitaxel in mice. Anti-Cancer Drug, 2003, 14, 203-209.
81. Cao, L. Y.; Xie, D.; Du, M. Research progress in pharmacokinetics of terpenoid drug in natural plant. Yunnan J. Tradit. Chin. Med. Mater. Med., 2008, 29, 56-58.
82. Chen, L. J.; Lebetkin, E. H.; Burka, L. T. Metabolism of (R) - (+)-pulegone in F344 rats. Drug Metab. Dispos., 2001, 29, 1567-1577.
83. Cassidy, A.; Hanley, B.; Lamuela-Raventos, R. M. Isoflavones, lignans and stilbenes-origins, metabolism and potential importance to human health. J. Sci. Food Agr., 2000, 80, 1044-1062.
84. n. Chin. Hosp. Pharm. J., 2008, 28, 978-981.
85. Yu, C.; Shin, Y. G.; Chow, A.; Li, Y. M.; Kosmeder, J. W.; Lee, Y. S.; Hirschelman, W. H.; Pezzuto, J. M.; Mehta, R. G.; van Breemen, R. B. Human, rat, and mouse metabolism of resveratrol. Pharm. Res., 2002, 19, 1907-1914.
86. Sun, J. H.; Zhang, L. T.; Wang, C. Y.; Yuan, Z. F.; Lu, X. H. Study on the metabolite of stilbene glucoside in mice by liquid chromatography tandemmass spectrometry. Acta Pharm. Sin., 2003, 38, 968-970.
87. Wang, C. Y.; Guo, D.; Yuan, Z. F.; Feng, X. L.; Zhang, L. T. Metabolism of stilbene glycoside in rats and in vitro. Chin. J. Pharm., 2009, 40, 120-123.
88. Silberberg, M.; Besson, C.; Manach, C.; Remesy, C.; Morand, C. Influence of dietary antioxidants on polyphenol intestinal absorption and metabolism in rats. J. Agr. Food Chem., 2006, 54, 3541-3546.
89. 3H-gastrodin in mice. J. Wcums., 1994, 25, 325-328.
90. Lu, G. W.; Zou, Y. J.; Chu, D. Q. Metabolism of gastrodin in rats. Chin. Pharm. Bull., 1986, 2, 23-25.
91. Wang, Q.; Chen, G. S.; Zeng, S. Study on the metabolism of gastrodin in rat brain, liver, kidney and different brain regions homogenate. Chin. Jmap., 2009, 26, 614-619.
92. Ni, S. M.; Qian, D. W.; Duan, J. A.; Guo, J. M.; Wang, Z. Z.; Shang, E. X.; Sun, G. L. Metablites of ligustilide and gastrodin from Dachuanxiong decoction in rabbit plasma. Chin. Tradit. Pat. Med., 2010, 32, 1115-1120.
93. Xie, M. Z.; Shen, Z. F. Absorption, distribution, excretion and metabolism of cryptotanshinone. Acta Pharm. Sin., 1983, 18, 90-96.
94. Xue, M.; Cui, Y.; Wang, H. Q.; Luo, Y. J.; Zhang, B.; Zhou, Z. T. Pharmacokinetics of cryptotanshinone and its metabolite pigs. Acta Pharm. Sin., 1999, 34, 81-84.
95. Xue, M.; Cui, Y.; Zhang, B.; Shi, Y. B.; Zhou, Z. T.; Luo, Y. J.; Xia, W. J.; Zhao, R. C.; Wang, H. Q. The metabolism of cryptotanshinone in pigs and in vitro. Chin. J. Vet. Sci., 1999, 19, 49-51.
96. Xue, M.; Zhang, B.; Cui, Y.; Shi, Y. B.; Luo, Y. J.; Zhou, Z. T.; Xia, W. J.; Zhao, R. C.; Wang, H. Q. Metabolic transformation of cryptotanshinone in pig liver microsomes P450. Chin. J. Vet. Sci. Technol., 1999, 29, 10-13.
97. Dai, H. X.; Wang, M. M.; Li, X. R.; Wang, L. J.; Li, Y. H.; Xue, M. Structural elucidation of in vitro and in vivo metabolites of cryptotanshinone by HPLC-DAD-ESI-MSn. J. Pharmaceut. Biomed. Anal., 2008, 48, 885-896.
98. Cui, Y. Y.; Wang, M. Z. Metabolic transformation of schizandrin. Acta Pharm. Sin., 1992, 27, 57-63.
99. Xu, M. J.; Wang, G. J.; Xie, H. T.; Huang, Q.; Jia, Y. W. Enzyme kinetics of schizandrin metabolism and sex differences in rat liver microsomes. Acta Pharm. Sin., 2007, 42, 730-734.
100. Cao, Y. F.; Zhang, Y. Y.; Li, J.; Ge, G. B.; Hu, D.; Liu, H. X.; Huang, T.; Wang, Y. C.; Fang, Z. Z.; Sun, D. X.; Huo, H.; Yin, J.; Yang, L. CYP3A catalyses schizandrin biotransformation in human, minipig and rat liver microsomes. Xenobiotica, 2010, 40, 38-47.
101. Peng, S. H.; Zhou, T. H. Investigation on in vivo metabolism of n-butyl phthalide. Acta Pharm. Sin., 1996, 31, 780-784.
102. Wang, C. H.; Feng, Y. P.; Wu, Y. L. A study on the metabolites of dl-3-nbutyphthalide in rats. Acta Pharm. Sin., 1997, 32, 641-646.